Related Experiment Video
Updated: Jun 23, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Immunotherapy: Vaccine trials in melanoma -- time for reflection
1Department of Surgical Oncology, Daniel den Hoed Cancer Center, Erasmus University MC, Rotterdam, The Netherlands. a.eggermont@erasmusmc.nl
Nature Reviews. Clinical Oncology
|April 25, 2009
Summary
Therapeutic vaccines failed to benefit advanced melanoma patients in large trials. Improved immune monitoring and adoptive T-cell therapy are now crucial for cancer treatment development.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Large randomized controlled trials investigated the efficacy of therapeutic vaccines in advanced and metastatic melanoma.
- These trials yielded disappointing results, demonstrating no significant benefit for patients receiving vaccines.
Discussion:
- The lack of vaccine efficacy necessitates a re-evaluation of current therapeutic vaccine development strategies for melanoma.
- There is a critical need for enhanced immune monitoring methodologies to assess treatment response and patient status.
Key Insights:
- Therapeutic vaccines do not improve outcomes for patients with advanced or metastatic melanoma.
- Advanced melanoma treatment requires exploring alternative immunotherapeutic approaches beyond conventional vaccines.
Outlook:
- Future research should focus on refining vaccine design or exploring novel immunotherapy combinations.
- Investigating advanced immune monitoring techniques, including adoptive T-cell therapy with lymphodepletion, is essential for improving melanoma patient care.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...